The 7-year-old son of Socastee High School’s head football coach is now cancer-free after battling a rare form of leukemia ...

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Amanda Faulkner, who had always considered herself healthy and active, was shocked to discover she had acute myeloid ...

Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros' OncotoX biologics program focused on acute myeloid leukemia ..

Jibraan, who planned to study Theoretical Physics, was in remission from a rare and aggressive form of acute myeloid leukemia and awaiting a life-saving stem cell transplant at University Hospital ...

A pair of identical twins only four and a half years old have become China's youngest-ever hematopoietic stem cell donors, ...